Stock Track | Pediatrix Medical Plummets 15.79% Intraday Following Q4 Earnings Miss on EPS and EBITDA

Stock Track

Feb 19

Pediatrix Medical Group's stock plummeted 15.79% during Thursday's intraday trading session. The sharp decline came as the market reacted to the company's latest financial results.

The healthcare services provider reported fourth-quarter adjusted earnings per share of $0.50, missing the analyst consensus estimate of $0.54. Additionally, the company's adjusted EBITDA of $65.845 million fell short of the estimated $71.1 million. While quarterly revenue of $493.771 million surpassed expectations, the earnings disappointment on key profitability metrics drove negative investor sentiment.

The company also provided its preliminary outlook for fiscal year 2026, projecting adjusted EBITDA in the range of $280 million to $300 million. The mixed financial picture, featuring an earnings miss alongside a revenue beat, appears to have prompted the significant sell-off in the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1141419852"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141419852\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141419852?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-19 22:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141419852","market":"nz","top_or_hot":-1,"title":"Stock Track | Pediatrix Medical Plummets 15.79% Intraday Following Q4 Earnings Miss on EPS and EBITDA","media":"Stock Track","content":"<p>Pediatrix Medical Group's stock plummeted 15.79% during Thursday's intraday trading session. The sharp decline came as the market reacted to the company's latest financial results.</p><p>The healthcare services provider reported fourth-quarter adjusted earnings per share of $0.50, missing the analyst consensus estimate of $0.54. Additionally, the company's adjusted EBITDA of $65.845 million fell short of the estimated $71.1 million. While quarterly revenue of $493.771 million surpassed expectations, the earnings disappointment on key profitability metrics drove negative investor sentiment.</p><p>The company also provided its preliminary outlook for fiscal year 2026, projecting adjusted EBITDA in the range of $280 million to $300 million. The mixed financial picture, featuring an earnings miss alongside a revenue beat, appears to have prompted the significant sell-off in the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Pediatrix Medical Plummets 15.79% Intraday Following Q4 Earnings Miss on EPS and EBITDA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Pediatrix Medical Plummets 15.79% Intraday Following Q4 Earnings Miss on EPS and EBITDA\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-19 22:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pediatrix Medical Group's stock plummeted 15.79% during Thursday's intraday trading session. The sharp decline came as the market reacted to the company's latest financial results.</p><p>The healthcare services provider reported fourth-quarter adjusted earnings per share of $0.50, missing the analyst consensus estimate of $0.54. Additionally, the company's adjusted EBITDA of $65.845 million fell short of the estimated $71.1 million. While quarterly revenue of $493.771 million surpassed expectations, the earnings disappointment on key profitability metrics drove negative investor sentiment.</p><p>The company also provided its preliminary outlook for fiscal year 2026, projecting adjusted EBITDA in the range of $280 million to $300 million. The mixed financial picture, featuring an earnings miss alongside a revenue beat, appears to have prompted the significant sell-off in the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MD","symbol_name":"Pediatrix Medical","start_time":0,"source_url":"","article_id":"1141419852","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141419852","pubTimestamp":1771511989,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Pediatrix Medical Group's stock plummeted 15.79% during Thursday's intraday trading session. The sharp decline came as the market reacted to the company's latest financial results.The healthcare...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MD":"Pediatrix Medical"},"translate_title":"个股追踪|Pediatrix Medical盘中暴跌15.79%，此前Q4盈利不及EPS和EBITDA","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MD":1},"content_text":"Pediatrix Medical Group's stock plummeted 15.79% during Thursday's intraday trading session. The sharp decline came as the market reacted to the company's latest financial results.The healthcare services provider reported fourth-quarter adjusted earnings per share of $0.50, missing the analyst consensus estimate of $0.54. Additionally, the company's adjusted EBITDA of $65.845 million fell short of the estimated $71.1 million. While quarterly revenue of $493.771 million surpassed expectations, the earnings disappointment on key profitability metrics drove negative investor sentiment.The company also provided its preliminary outlook for fiscal year 2026, projecting adjusted EBITDA in the range of $280 million to $300 million. The mixed financial picture, featuring an earnings miss alongside a revenue beat, appears to have prompted the significant sell-off in the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}